Table 1. Summary of MS-PCR parameters.
Gleason score |
||||
---|---|---|---|---|
(a) | # of genes hypermethylated | 1–4 | 5–7 | 8–10 |
P=0.1781 | 0–1 | 3 | 28 | 14 |
2–3 | 0 | 15 | 10 | |
4 | 1 | 34 | 8 | |
Tumour stage |
||||
pT1–2 | pT3–4 | |||
P=0.2024 | 0–1 | 24 | 21 | |
2–3 | 10 | 15 | ||
4 | 15 | 28 | ||
Lymph node status |
||||
N0 | N+ | |||
P=0.4817 | 0–1 | 39 | 6 | |
2–3 | 19 | 6 | ||
4 | 34 | 9 | ||
Gleason score |
||||
(b) | Hypomethylation | 1–4 | 5–7 | 8–10 |
P=0.5937 | 0–3% | 1 | 40 | 14 |
4–12% | 2 | 24 | 9 | |
>12% | 1 | 13 | 9 | |
Tumour stage |
||||
pT1–2 | pT3–4 | |||
P=0.04187 | 0–3% | 29 | 26 | |
4–12% | 15 | 20 | ||
>12% | 5 | 18 | ||
Lymph node status |
||||
N0 | N+ | |||
P=0.08172 | 0–3% | 47 | 8 | |
4–12% | 30 | 5 | ||
>12% | 15 | 8 |
For each gene the primer sequences used, the annealing temperatures, and the number of cycles are indicated. M=methylated-specific primers; U=unmethylated-specific primers; BS=primers used for bisulphite sequencing.